| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 1 |
| 1 | ACETAMINOPHEN 500MG | 1 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 3 | ADALIMUMAB | 1 |
| 4 | ADALIMUMAB-AATY | 1 |
| 5 | ADALIMUMAB-ADAZ | 1 |
| 6 | ADALIMUMAB-FKJP | 1 |
| 7 | BENDAMUSTINE HYDROCHLORIDE | 1 |
| 8 | CYTARABINE | 1 |
| 9 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 1 | 0.0006 |
| 1 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0003 |
| 2 | DUTASTERIDE | 1 | 0.0001 |
| 3 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 4 | ADALIMUMAB-FKJP | 1 | 0.0000 |
| 5 | ADALIMUMAB-AATY | 1 | 0.0000 |
| 6 | ADALIMUMAB-ADAZ | 1 | 0.0000 |
| 7 | CYTARABINE | 1 | 0.0000 |
| 8 | IBRUTINIB | 1 | 0.0000 |
| 9 | NATALIZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 1 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Thalidomide Analog [EPC] | 1 | 0.0000 |
| 5 | Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |